Mary Beth Henry, NP Print Friendly Page
Mary Beth Henry is a member of the multidisciplinary hepatobiliary/pancreas surgical oncology, melanoma, primary liver tumor, and the sarcoma teams. She cares for patients with benign and malignant diseases of the stomach, liver, gallbladder and pancreas, and patients with skin and soft tissue malignancies. Mary Beth is an associate member of the Americas Hepato-Pancreato-Biliary Association and is involved in the Oncology Nursing Society. She has also organized a number of local events to raise funds for surgical outcomes research, and has been instrumental in the development of a number of funds designed to provide direct assistance to cancer patients.
UW Health Clinics
UW School of Medicine and Public Health
|Department of Surgery|
Professional Certifications and Education
Acute Care Nurse Practicioner (ACNP)
Alverno College, Milwaukee, WI
University of Wisconsin - Madison, Madison, WI
|Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.|
About Nurse Practitioners (NPs)
|At UW Health, nurse practitioners work together on teams with physicians to provide direct medical care to patients of all ages across primary, specialty, hospital and long-term care settings. A nurse practitioner is a registered nurse with a master's or doctorate degree. They have advanced education, training and certification in the diagnosis, management, prevention and treatment of common and complex medical conditions. Nurse practitioners are also referred to as advanced practice registered nurses (APRNs) and advanced practice providers (APPs). Their training focuses on nursing and medical models of care, overall health and wellness.
For more information about Nurse Practitioners, please see our brochure.
Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.
Mary Beth assists principal investigators in several clinical trials focusing on the treatment of metastatic melanoma and hepatobiliary/pancreas cancers.